Both medications are given as a once-weekly subcutaneous injection and share similar pharmacokinetic characteristics, such as absorption, distribution, metabolism, and excretion
cons It lacks advanced automation features that some other tools offer
Some even questioned whether the data truly reflected the batterys performance
9 Whether that in vitro signal matters for a human eating normal amounts is still unknown
Safety Considerations When Combining Metformin with GLP-1 Therapy The primary safety consideration involves gastrointestinal side effects, which occur more frequently when GLP-1 medications are introduced, particularly nausea and constipation during dose escalation phases
doi:10.1089/acm.2010.0716 Rachel Erwin, Nutritionist & Content Writer Rachel is a Nutritionist with a BSc in Biology and Global Health from the University of Toronto, and a Postgraduate Diploma in Human Nutrition from the University of Ulster